Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery
Surgical Endoscopy · 2024
DOI: 10.1007/s00464-024-10857-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Eigo Akimoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastric Surgery Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Laparoscopy, Robotic Surgical Procedures, Feasibility Studies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Laparoscopic surgery for early gastric cancer is regarded as a standard of care because of robust evidences obtained by several phase-III trials. Furthermore, the efficacy of laparoscopic radical surgery for advanced gastric cancer has been also reported. Meanwhile, the feasibility of laparoscopic surgery for Bormann type 4 gastric cancer, special type with unfavorable prognosis, remains unclear since excluded from eligibility of these trials. METHODS: This study included 100 patients with type 4 gastric cancer who underwent laparoscopic/robot-assisted (minimally invasive surgery (MIS) group; n = 32) or open (Open group; n = 68) curative surgery between 2008 and 2021. After propensity score matching, 30 patients in each group were extracted for analysis. Clinical data, including surgical and midterm survival outcomes, were retrospectively compared between the two groups. RESULTS: Incidences of postoperative complication (≥ Clavien-Dindo grade III) were recorded in 23.3% in the MIS group and 13.3% in the Open group, but no statistical significance was demonstrated (P = 0.50). The 3-year overall survival rate in the MIS group was better than that in the Open group (80.2% vs. 53.5%, log-rank, P = 0.03). The trend of recurrence site was similar. Multivariate analysis showed that adjuvant chemotherapy was an independent favorable prognostic factor (hazard ratio, 0.33, 95% confidence interval 0.11-0.93) for overall survival. MIS was indicated as a favorable prognostic factor (hazard ratio, 0.39, 95% confidence interval 0.39-1.07), but without statistical difference. CONCLUSION: While multidisciplinary treatment is mainstay of treatment because of the poor prognosis of this disease, minimally invasive surgery may play an important role in treatment if appropriate patient selection is done. Further analyses with larger sample size are necessary to reach a final conclusion regarding oncological efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastric Surgery Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
- Gastric Surgery Division, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. takkinos@east.ncc.go.jp.
ORCID-Profile: Takahiro Kinoshita
Zitieren
APA
Akimoto, E., Kinoshita, T., Yura, M., Yoshida, M., Okayama, T., Habu, T., Komatsu, M., Nagata, H., & Terajima, D. (2024). Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-10857-0
Vancouver
Akimoto E, Kinoshita T, Yura M, Yoshida M, Okayama T, Habu T, et al. Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-10857-0
BibTeX
@article{Akimoto2024,
author = {Akimoto, Eigo and Kinoshita, Takahiro and Yura, Masahiro and Yoshida, Mitsumasa and Okayama, Takafumi and Habu, Takumi and Komatsu, Masaru and Nagata, Hiromi and Terajima, Daiki},
title = {Feasibility of laparoscopic/robot-assisted surgery for Borrmann type 4 gastric cancer: a comparison study with conventional open surgery},
journal = {Surgical Endoscopy},
year = {2024},
doi = {10.1007/s00464-024-10857-0}
}
EUVIMED